Identification of Key Factors Associated with Early- and Late-Onset Ovarian Serous Cystadenocarcinoma
Aim: To uncover the molecular mechanisms of early-onset ovarian serous cystadenocarcinoma (EOOSC; patients <50 years old) and late-onset ovarian serous cystadenocarcinoma (LOOSC; patients ≥50 years old). Materials & methods: Bioinformatics was utilized to identify the key factors. Results: 478 EOOSC and 899 LOOSC individual differentially expressed genes were identified and enriched in different pathways. The expression of key genes LAG3, LRRC63 and MT1B significantly influenced the overall survival of EOOSC patients. The expression of key genes RDH12, NTSR1, ZSCAN16, CT45A3 and EPPIN_WFDC6 significantly affected the overall survival of LOOSC patients. Conclusions: The molecular mechanisms of EOOSC and LOOSC appear to be different, so that patients might be treated individually in respect of age. The chances of surviving ovarian cancer decrease as you get older. Ovarian serous cystadenocarcinoma is the most common and deadly type of ovarian cancer. Research has shown that there are differences between younger and older patients in relation to how the cancerous ovarian serous cystadenocarcinoma tumor behaves and how the body responds to the cancer. Our research is the first to show which genes could be responsible for these differences and which genes become more or less active as you grow older. Our results suggest that ovarian serous cystadenocarcinoma patients might need to be treated differently with respect to their ages.
Authors
- 费承伟
- Shuang Ma
- Yang Zheng
Publication Details
- Journal
- Figshare
- Published
- 2026-11-12
- DOI
- https://doi.org/10.6084/m9.figshare.34998061
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00